Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05807919 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of the Mediterranean Diet to the Low- Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Treating Irritable Bowel Syndrome(IBS)
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05807919 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 26 participants.
The verdict
NCT05807919, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is being completed to determine if the Mediterranean (MD) and low FODMAP (fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols) diets are comparable in the effectiveness to treat Irritable Bowel Syndrome (IBS). The study team hypothesizes that: * The low FODMAP and Mediterranean groups will achieve a similar improvement in abdominal pain * Both groups will achieve similar improvements in bloating, overall IBS symptom severity, and adequate relief
Interventions
- OTHER Diet low in all FODMAP groups
- OTHER Diet - Mediterranean
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-04-10 |
| Est. Completion | 2023-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05807919
The ClinicalTrials.gov registry entry for NCT05807919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diet low in all FODMAP groups is the first listed.
NCT05807919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05807919 about?
NCT05807919 is a clinical study titled "Evaluating the Efficacy of the Mediterranean Diet to the Low- Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Treating Irritable Bowel Syndrome(IBS)". This study is being completed to determine if the Mediterranean (MD) and low FODMAP (fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols) diets are comparable in the effectiveness to treat Irritable Bowel Syndrome (IBS). The study team hypothesizes that: * The low FODMAP and...
What is the current status of trial NCT05807919?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-04-10. Estimated completion is 2023-11-03.
What interventions are being tested in trial NCT05807919?
The interventions under investigation include: Diet low in all FODMAP groups (OTHER), Diet - Mediterranean (OTHER).
Who is sponsoring clinical trial NCT05807919?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.